Transcriptional Mechanisms of Drug Addiction | NIH Lecture 2009

Added:

Addiction as Plasticity
DeltaFosB Induction
Natural Reward Effects
Behavioral Impact
Chromatin Mechanisms
Global Chromatin Shifts
Genomic Integration
Neuronal Structure

Addiction as Plasticity

4:09
Playing Section
  • 1

    Addiction is a form of drug-induced neuroplasticity requiring repeated exposure.

  • 2

    Repeated drug use alters gene expression via transcription factors in brain reward regions.

  • 3

    Research focuses on molecular changes underlying long-lasting relapse vulnerability.

Basic principles of eukaryotic gene transcription and the role of transcription factors in regulating gene expression.
The structural organization of chromatin, including nucleosomes, histones, and the basics of epigenetic modifications.
The neuroanatomy and pharmacology of the brain's reward system, particularly the mesolimbic dopamine pathway.
Intracellular signal transduction pathways, specifically GPCR signaling and the cAMP/PKA cascade that activates CREB.
The study of epigenetic-based therapeutics, such as HDAC inhibitors, as potential treatments for substance use disorders.
How stable chromatin remodeling translates to long-term synaptic plasticity and structural changes in neurons (e.g., dendritic spine density).
Advanced molecular techniques used to map epigenetic landscapes in the brain, such as ChIP-seq and ATAC-seq.
The role of other epigenetic factors, such as microRNAs and DNA methylation, in the persistence of drug-seeking behavior and vulnerability to relapse.
9.3K views60likes54:30@NIHVideoCastOriginal Release: 2012-08-30

Addiction is a form of drug-induced neural plasticity where repeated drug exposure produces stable changes in gene expression through transcription factors like Delta FosB, which accumulates in the nucleus accumbens and regulates target genes to produce long-lasting behavioral adaptations; this process involves chromatin remodeling that modifies histone acetylation and methylation patterns, creating a molecular switch that distinguishes acute drug effects from chronic addiction states.